1.6(top 10%)
Impact Factor
1.8(top 10%)
extended IF
77(top 5%)
H-Index
1.2K
authors
3.3K
papers
56.4K
citations
2.2K
citing journals
13.7K
citing authors

Most Cited Articles of Antiviral Therapy

TitleYearCitations
Silver Nanoparticles Inhibit Hepatitis B virus Replication2008295
Silver nanoparticles inhibit hepatitis B virus replication2008268
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience2018216
Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir2005183
Response-Guided Therapy: Optimizing Treatment now and in the Future2008179
Long-Term Lamivudine Therapy Reduces the Risk of Long-Term Complications of Chronic Hepatitis B Infection even in Patients without Advanced Disease2007175
Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment2008169
Human coronaviruses: what do they cause?2007167
Susceptibility of HIV-2, Siv and Shiv to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure Prophylaxis2004161
The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan2000160
Human Coronaviruses: What Do They Cause?2007153
Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome2016147
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D2010143
Management of Antiviral Resistance in Patients with Chronic Hepatitis B2004139
Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods2012136
In vitro Selection and Characterization of HIV-1 with Reduced Susceptibility to PMPA1999136
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study2010134
A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan2006133
Hepatitis B surface antigen seroclearance during chronic HBV infection2010128
Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial2008125
HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B2011122
Impact of Neuraminidase Mutations Conferring Influenza Resistance to Neuraminidase Inhibitors in the N1 and N2 Genetic Backgrounds2006122
Molecular genetics of HBV infection2010120
The World Health Organization's global strategy for prevention and assessment of HIV drug resistance2008120
In Vitro Susceptibility of Adefovir-Associated Hepatitis B Virus Polymerase Mutations to other Antiviral Agents2007119